Tumour metastasis to the liver, and the roles of proteinases and adhesion molecules: New concepts from in vivo videomicroscopy

Canadian Journal of Gastroenterology

Volumn 13, Issue 9, 1999, Pages 733-743

  Groom, Alan C ^a   MacDonald, Ian C ^a   Schmidt, Eric E ^a   Morris, Vincent L ^a   Chambers, Ann F ^a,b  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b LONDON REGIONAL CANCER PROGRAM   (Canada)

Author keywords

In vivo assays; Integrins; Liver; Matrix metalloproteinases; Metastasis; Videomicroscopy

Indexed keywords

CELL ADHESION MOLECULE; MATRIX METALLOPROTEINASE INHIBITOR; METALLOPROTEINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; CANCER CELL; CELL GROWTH; CELL MIGRATION; CELL SUBPOPULATION; CELL SURVIVAL; EXTRAVASATION; HUMAN; HUMAN CELL; LIVER METASTASIS; METASTASIS POTENTIAL; MICROCIRCULATION; MICROSCOPY; NONHUMAN; PRIORITY JOURNAL; REVIEW; RHABDOMYOSARCOMA;

EID: 0033404461     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/1999/935947     Document Type: Review

References (47)

1. 125I-5-iodo-2′-deoxyuridine. J Natl Cancer Inst 1970;45:773-82.
2. Butler TP, Gullino PM. Quantitation of cells shedding into efferent blood of mammary adenocarcinoma. Cancer Res 1975;35:512-6.
3. Mayhew E, Glaves D. Quantification of tumorigenic disseminating and arrested cancer cells. Br J Cancer 1984;50:159-66.
4. Weiss L. Metastatic inefficiency. Adv Cancer Res 1990;54:159-211.
5. Weiss L. The biomechanics of cancer cell traffic, arrest, and intravascular destruction. In: Orr FW, Buchanan MR, Weiss L, eds. Microcirculation in Cancer Metastasis. Boca Raton: CRC Press, 1991:131-44.
6. Hanna N. Role of natural killer cells in control of cancer metastasis. Cancer Metastasis Rev 1982;1:45-64.
7. Key M. Macrophages in cancer metastasis and their relevance to metastatic growth. Cancer Metastasis Rev 1983;2:75-88.
8. Chambers AF, MacDonald IC, Schmidt EE, et al. Steps in tumor metastasis: new concepts from intravital videomicroscopy. Cancer Metastasis Rev 1995;14:279-301.
9. MacDonald IC, Schmidt EE, Morris VL, Groom AC, Chambers AF. In vivo videomicroscopy of experimental hematogenous metastasis: cancer cell arrest, extravasation, and migration. In: Soil DR, Wessels D, eds. Motion Analysis of Living Cells. New York: John Wiley &. Sons, Inc, 1998:263-85.
10. Morris VL, Koop S, MacDonald IC, et al. Mammary carcinoma cell lines of high and low metastatic potential differ not in extravasation but in subsequent migration and growth. Clin Exp Metastasis 1994;12:357-67.
11. Chishima T, Miyagi Y, Wang X, et al. Cancer invasion and micrometastasis visualized in live tissue by green fluorescent protein expression. Cancer Res 1997;57:2042-7.
12. Farina KL, Wyckoff JB, Rivera J, et al. Cell motility of tumor cells visualized in living intact primary tumors using green fluorescent protein. Cancer Res 1998;58:2528-32.
13. Naumov GN, Wilson SM, MacDonald IC, et al. Cellular expression of green fluorescent protein coupled with high-resolution in vivo videomicroscopy, to monitor steps in tumor metastasis. J Cell Sci 1999;112:1835-42.
14. R B16F1 murine melanoma cells to assess clonality of experimental metastases in the immune-deficient chick embryo. Clin Exp Metastasis 1988;6:171-82.
15. Talmadge JE, Wolman SR, Fidler IJ. Evidence for the clonal origin of spontaneous metastases. Science 1982;217:361-3.
16. Talmadge JE, Zbar B. Clonality of pulmonary metastases from the bladder 6 subline of the B16 melanoma studied by Southern hybridization. J Natl Cancer Inst 1987;78:315-20.
17. Koop S, MacDonald IC, Luzzi K, et al. Fate of melanoma cells entering the microcirculation: over 80% survive and extravasate. Cancer Res 1995;55:2520-3.
18. Luzzi KJ, MacDonald IC, Schmidt EE, et al. Multistep nature of metastatic inefficiency: Dormancy of solitary cells after successful extravasation, and limited survival of early micrometastases. Am J Pathol 1998;153:865-73.
19. Morris VL, MacDonald IC, Koop S, Schmidt EE, Chambers AF, Groom AC. Early interactions of cancer cells with the microvasculature in mouse liver and muscle during hematogenous metastasis: videomicroscopic analysis. Clin Exp Metastasis 1993;11:377-90.
20. Morris VL, Schmidt EE, Koop S, et al. Effects of the disintegrin eristostatin on individual steps of hematogenous metastasis. Exp Cell Res 1995;219:571-8.
21. 1) function in postextravasation movement of human rhabdomyosarcoma RD cells in the liver. Cancer Res 1996;56:3142-9.
22. Koop S, Khokha R, Schmidt EE, et al. Overexpression of metalloproteinase inhibitor in B16F10 cells does not affect extravasation but reduces tumor growth. Cancer Res 1994;54:4791-7.
23. Koop S, Schmidt EE, MacDonald IC, et al. Independence of metastatic ability and extravasation: Metastatic ras-transformed and control fibroblasts extravasate equally well. Proc Natl Acad Sci USA 1996;93:11080-4.
24. Thorlacius H, Prieto J, Raud J, et al. Tumor cell arrest in the microcirculation: lack of evidence for a leukocyte-like rolling adhesive interaction with vascular endothelium in vivo. Clin Immunol Immunopathol 1997;83:68-76.
25. Scherbarth S, Orr FW. Intravital videomicroscopic evidence for regulation of metastasis by the hepatic microvasculature: effects of interleukin-1α on metastasis and the location of B16F1 melanoma cell arrest. Cancer Res 1997;57:4105-10.
26. Weiss L. The hemodynamic destruction of circulating cancer cells. Biorheology 1987;24:105-15.
27. Weiss L, Nannmark U, Johansson BR, Bagge U. Lethal deformation of cancer cells in the circulation: A potential rate regulator of hematogenous metastasis. Int J Cancer 1992;50:103-7.
28. Chew EC, Josephson RL, Wallace AC. Morphologic aspects of the arrest of circulating cancer cells. In: Weiss L, ed. Fundamental Aspects of Metastasis. Amsterdam: North-Holland, 1976:121-50.
29. Crissman JD, Hatfield JS, Schaldenbrand M, Sloan B, Honn KV. Arrest and extravasation of B16 amelanotic melanoma in murine lungs: A light and electron microscopic study. Lab Invest 1985;53:470-8.
30. Crissman JD, Hatfield JS, Menter DG, Sloan B, Honn KV. Morphological study of the interaction of intravascular tumor cells with endothelial cells and subendothelial matrix. Cancer Res 1988;48:4065-72.
31. Dingeman KP, Roos E. Ultrastructural aspects of the invasion of liver by cancer cells (II). In: Weiss L, Gilbert HA, eds. Liver Metastasis. Boston: GK Hall Medical Publishers, 1982:51-76.
32. Ausprunk D, Dethlefson S, Higgins E. Distribution of fibronectin, laminin and type IV collagen during development of blood vessels in the chick chorioallantoic membrane. In: Feinberg R, Sherer G, Auerbach R, eds. The Development of the Vascular System. Basel: S Karger, 1991:93-108.
33. Ruoslahti E, Reed JC. Anchorage dependence, integrins, and apoptosis. Cell 1994;77:477-8.
34. Bates RC, Lincz LF, Burns GF. Involvement of integrins in cell survival. Cancer Metastasis Rev 1995;14:191-203.
35. 1 integrin in mouse liver. Mol Biol Cell 1997;8:1863-75.
36. Wheelock EF, Weinhold KJ, Levich J. The tumor dormant state. Adv Cancer Res 1981;34:107-40.
37. Hadfield G. The dormant cancer cell. Br Med J 1954;ii:607-9.
38. Giancotti FG, Ruoslahti E. Elevated levels of the alpha 5 beta 1 fibronectin receptor suppress the transformed phenotype of Chinese hamster ovary cells. Cell 1990;60:849-59.
39. Chan BM, Matsuura N, Takada Y, Zetter BR, Hemler ME. In vitro and in vivo consequences of VLA-2 expression on rhabdomyosarcoma cells. Science 1991;251:1600-2.
40. Qian F, Vaux DL, Weissman IL. Expression of the integrin alpha 4 beta 1 on melanoma cells can inhibit the invasive stage of metastasis formation. Cell 1994;77:335-47.
41. Khokha R, Zimmer MJ, Wilson SM, Chambers AF. Up-regulation of TIMP-1 expression in B16-F10 melanoma cells suppresses their metastatic ability in chick embryo. Clin Exp Metastasis 1992;10:365-70.
42. Khokha R. Suppression of the tumorigenic and metastatic abilities of murine B16-F10 melanoma cells in vivo by the overexpression of the tissue inhibitor of the metalloproteinases-1. J Natl Cancer Inst 1994;86:299-304.
43. Khokha R, Zimmer MJ, Graham CH, Lala PK, Waterhouse P. Suppression of invasion by inducible expression of tissue inhibitor of metalloproteinase-1 (TIMP-1) in B16-F10 melanoma cells. J Natl Cancer Inst 1992;84:1017-22.
44. Wylie S, MacDonald IC, Varghese HJ, et al. The matrix metalloproteinase inhibitor batimastat inhibits angiogenesis in liver metastases of B16F1 melanoma cells. Clin Exp Metastasis 1999;17:111-7.
45. Brown PD. Matrix metalloproteinase inhibitors: a novel class of anticancer agents. Advances Enzyme Regul 1995;35:293-301.
46. Chambers AF, Matrisian LM. Changing views of the role of matrix metalloproteinases in metastasis. J Natl Cancer Inst 1997;89:1260-70.
47. MacDonald IC, Schmidt EE, Morris VL, Chambers AF, Groom AC. Intravital videomicroscopy of the chorioallantoic microcirculation: A model system for studying metastasis. Microvasc Res 1992;44:185-99.